Regulation of bone loss by IL-23/IL-17A axis in inflammatory arthritis
IL-23/IL-17A 轴对炎性关节炎中骨丢失的调节
基本信息
- 批准号:8448647
- 负责人:
- 金额:$ 32.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdultAllelesAmericanAnimalsAnkylosing spondylitisArthritisAutoimmune DiseasesAutoimmune ProcessBindingBone MarrowCD4 Positive T LymphocytesCalcium SignalingCellsClinicalComputersCytoplasmic TailDiseaseDissectionF-ActinGene TransferGenesHelper-Inducer T-LymphocyteHematopoieticHistologyHumanITAMITGAM geneITGAX geneImmuneInflammationInflammatoryInflammatory Bowel DiseasesInterleukin-17MDL-1 receptorMeasuresMediatingMemoryModelingMolecularMonitorMultiple SclerosisMusMyelogenousMyeloid Cell ActivationMyeloid CellsOsteoclastsPathogenesisPathway interactionsPhagocytesPhosphorylationPolymerasePopulationPsoriatic ArthritisRNA-Directed DNA PolymeraseReactionRegulationReporterResearchRheumatoid ArthritisRoleSerumSignal TransductionSingle Nucleotide PolymorphismSorting - Cell MovementSystemSystemic Lupus ErythematosusT-LymphocyteTEC Protein Tyrosine KinaseTYROBP geneTherapeutic InterventionTranslatingaging populationautoimmune arthritisbonebone losscytokinedesigneconomic impactgenome-widehuman EMS1 proteinhuman SYK proteinin vivoinsightinterleukin-23kinase inhibitornovelnovel therapeuticsnuclear factors of activated T-cellsosteoclastogenesispreventprogenitorreceptorresponseskeletalsrc-Family Kinasestomography
项目摘要
DESCRIPTION (provided by applicant): About 50 million Americans (22%) suffer from some form of arthritis and estimates are that, with the aging population worldwide, 67 million adults will have arthritis by 2030 with an economic impact higher than $128 billion dollars. Although interleukin-23 (IL-23) has been implicated in the pathogenesis of arthritis, the molecular mechanisms remain unknown. Since the discovery of IL-23 regulation of pathogenic T helper cells that express interleukin-17 (Th17) the importance of direct actions of IL-23 in arthritis is overshadowed. To highlight its importance we developed gene-transfer models of IL-23 and IL-17A and using these models we established that IL-23 is a potent inducer of arthritis, independently of IL-17A. Dissection of IL-23 from the IL- 23/IL-17A axis has allowed us to uncover novel mechanisms of myeloid cell activation previously overlooked. We identified that IL-23 induces arthritis independently of Th17 cells and through activation of myeloid cells. T cells and myeloid cells share a requirement for costimulatory signals that are mediated by ITAMs. The ITAM is a conserved signaling motif contained in the cytoplasmic domain of transmembrane adaptor molecules that are associated and transmit signals from various immunoreceptors present in haematopoietic progenitors. These signals orchestrate synovial inflammation and differentiation of myeloid cells to bone resorbing cells called osteoclasts. Discovering the cellular and molecular mechanisms that dictate recruitment and activation of osteoclasts in inflammatory arthritis is central to preventing this disabling condition. Detailed understanding of these cellular and molecular interactions will yield insights into regulation of arthritis that can be exploited for therapeutic interventions.
描述(由申请人提供):大约5000万美国人(22%)患有某种形式的关节炎,估计是,随着全球衰老的人口年龄,有6700万成年人将于2030年患有关节炎,经济影响高于1.28亿美元。尽管白介素23(IL-23)与关节炎的发病机理有关,但分子机制仍然未知。由于发现了表达白介素17(TH17)的致病性T辅助细胞的IL-23调节,因此IL-23在关节炎中的直接作用的重要性被掩盖了。为了强调其重要性,我们开发了IL-23和IL-17A的基因转移模型,并使用这些模型确定IL-23是关节炎的有效诱导剂,独立于IL-17A。从IL-23/IL-17A轴对IL-23的解剖使我们能够发现以前被忽略的髓样细胞激活的新型机制。我们确定IL-23独立于TH17细胞和通过激活髓样细胞诱导关节炎。 T细胞和髓样细胞对ITAMS介导的共刺激信号的需求。 ITAM是跨膜衔接子分子的细胞质结构域中包含的保守信号基序,与造血祖细胞中存在的各种免疫受体相关的信号相关联。这些信号将骨髓炎症和分化的髓样细胞与称为破骨细胞的骨吸收细胞分化。发现决定炎症性关节炎中破骨细胞的募集和激活的细胞和分子机制对于防止这种残疾状况至关重要。对这些细胞和分子相互作用的详细理解将产生可用于治疗干预措施的关节炎调节的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Iannis Elias Adamopoulos其他文献
Iannis Elias Adamopoulos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Iannis Elias Adamopoulos', 18)}}的其他基金
Immune mechanisms of pain of the IL-23IL-17 Axis in Inflammatory Arthritis
炎症性关节炎中 IL-23IL-17 轴疼痛的免疫机制
- 批准号:
10861492 - 财政年份:2023
- 资助金额:
$ 32.92万 - 项目类别:
The IL-23/IL-17 Axis in Inflammatory Arthritis
炎症性关节炎中的 IL-23/IL-17 轴
- 批准号:
10413524 - 财政年份:2021
- 资助金额:
$ 32.92万 - 项目类别:
The IL-23/IL-17 Axis in Inflammatory Arthritis
炎症性关节炎中的 IL-23/IL-17 轴
- 批准号:
10529133 - 财政年份:2021
- 资助金额:
$ 32.92万 - 项目类别:
The IL-23/IL-17 Axis in Inflammatory Arthritis
炎症性关节炎中的 IL-23/IL-17 轴
- 批准号:
10307090 - 财政年份:2021
- 资助金额:
$ 32.92万 - 项目类别:
The IL-23/IL-17 Axis in Inflammatory Arthritis
炎症性关节炎中的 IL-23/IL-17 轴
- 批准号:
10077832 - 财政年份:2020
- 资助金额:
$ 32.92万 - 项目类别:
The IL-23/IL-17 Axis in Inflammatory Arthritis
炎症性关节炎中的 IL-23/IL-17 轴
- 批准号:
10449669 - 财政年份:2020
- 资助金额:
$ 32.92万 - 项目类别:
The IL-23/IL-17 Axis in Inflammatory Arthritis
炎症性关节炎中的 IL-23/IL-17 轴
- 批准号:
9763801 - 财政年份:2020
- 资助金额:
$ 32.92万 - 项目类别:
Role of splicing factor SRSF1 in T cell function and autoimmunity
剪接因子 SRSF1 在 T 细胞功能和自身免疫中的作用
- 批准号:
10093179 - 财政年份:2016
- 资助金额:
$ 32.92万 - 项目类别:
Regulation of bone loss by IL-23/IL-17A axis in inflammatory arthritis
IL-23/IL-17A 轴对炎性关节炎中骨丢失的调节
- 批准号:
8734726 - 财政年份:2013
- 资助金额:
$ 32.92万 - 项目类别:
Regulation of bone loss by IL-23/IL-17A axis in inflammatory arthritis
IL-23/IL-17A 轴对炎性关节炎中骨丢失的调节
- 批准号:
8824488 - 财政年份:2012
- 资助金额:
$ 32.92万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the role of a conserved serine/threonine kinase, SAX-1, in higher-order dendrite pruning
研究保守丝氨酸/苏氨酸激酶 SAX-1 在高阶树突修剪中的作用
- 批准号:
10709511 - 财政年份:2022
- 资助金额:
$ 32.92万 - 项目类别:
Generation and Characterization of Novel Large Animal Models of Usher Syndrome Type 3
3 型亚瑟综合症新型大型动物模型的生成和表征
- 批准号:
10706969 - 财政年份:2022
- 资助金额:
$ 32.92万 - 项目类别:
Investigating the role of a conserved serine/threonine kinase, SAX-1, in higher-order dendrite pruning
研究保守丝氨酸/苏氨酸激酶 SAX-1 在高阶树突修剪中的作用
- 批准号:
10537345 - 财政年份:2022
- 资助金额:
$ 32.92万 - 项目类别: